Randomized, Multicenter, Double-Blind Study of Efficacy, Safety, And Tolerability of Intravenous Ertapenem Versus Piperacillin/Tazobactam in Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults

医学 厄他培南 哌拉西林/他唑巴坦 耐受性 哌拉西林 他唑巴坦 随机对照试验 腹部外科 麻醉 双盲 美罗培南 外科 不利影响 内科学 抗生素 安慰剂 病理 替代医学 细菌 铜绿假单胞菌 抗生素耐药性 微生物学 生物 遗传学
作者
Nicholas Namias,Joseph S. Solomkin,Erin Jensen,Joanne E. Tomassini,Murray A. Abramson
出处
期刊:Surgical Infections [Mary Ann Liebert]
卷期号:8 (1): 15-28 被引量:50
标识
DOI:10.1089/sur.2006.030
摘要

Background: Complicated intra-abdominal infections are a common problem in surgical practice. This study compared the effectiveness of ertapenem (1 g qd) and piperacillin/tazobactam (3.375 g q6h) in the treatment of these infections. Methods: This was a multicenter, double-blinded, randomized study conducted in patients with complicated intra-abdominal infections. Of the 535 patients screened, 500 were stratified on the basis of disease severity (Acute Physiology and Chronic Health Evaluation [APACHE] II score ≤10 or >10), then randomized (1:1) to 4–14 days of treatment with one of the regimens and six weeks of followup. Nearly all patients (N = 494) were treated. The primary endpoint was the proportion of microbiologically evaluable patients with a favorable clinical response (cure) at two weeks. Non-inferiority of ertapenem was based on a difference in response rate of <15 percentage points compared with piperacillin/tazobactam (lower bound of the 95% CI > −15). Results: Of the 494 treated patients, 231 were microbiologically evaluable, with 123 and 108 patients in the ertapenem and piperacillin/tazobactam groups, respectively. Statistically similar cure rates were observed in the ertapenem (82.1%) and piperacillin/tazobactam (81.7%) groups (difference 0.3 [95% CI: −9.6, 10.5]). The pathogens isolated most frequently were Escherichia coli, Bacteroides fragilis, and Bacteroides thetaiotamicron, typical isolates associated with intra-abdominal infections. There were no statistical differences between the groups in serious drug-related clinical adverse events, drug-related clinical adverse experiences leading to study discontinuation, or mortality. Conclusions: Ertapenem was non-inferior to piperacillin/tazobactam in the cure of intra-abdominal infections caused by susceptible pathogens. Both study drugs generally were well tolerated.

科研通智能强力驱动
Strongly Powered by AbleSci AI

祝大家在新的一年里科研腾飞
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
壮观人达发布了新的文献求助10
1秒前
舒心的雍应助ixueyi采纳,获得10
1秒前
oi完成签到 ,获得积分10
7秒前
8秒前
reece完成签到 ,获得积分10
9秒前
nini发布了新的文献求助10
14秒前
ixueyi完成签到,获得积分10
16秒前
时尚的诗珊完成签到 ,获得积分10
16秒前
17秒前
17秒前
17秒前
17秒前
17秒前
18秒前
18秒前
18秒前
18秒前
18秒前
Ava应助科研通管家采纳,获得10
19秒前
charint应助科研通管家采纳,获得10
19秒前
所所应助科研通管家采纳,获得10
19秒前
蓝天应助科研通管家采纳,获得10
19秒前
SPARK应助科研通管家采纳,获得10
19秒前
charint应助科研通管家采纳,获得10
19秒前
charint应助科研通管家采纳,获得10
19秒前
NattyPoe应助科研通管家采纳,获得30
19秒前
SPARK应助科研通管家采纳,获得10
19秒前
ding应助科研通管家采纳,获得20
19秒前
Hello应助科研通管家采纳,获得10
19秒前
SPARK应助科研通管家采纳,获得10
19秒前
拾柒完成签到,获得积分10
20秒前
qiqi完成签到,获得积分10
24秒前
28秒前
JooYer完成签到 ,获得积分10
29秒前
123发布了新的文献求助10
33秒前
42秒前
zhfliang完成签到,获得积分10
46秒前
48秒前
whs完成签到 ,获得积分10
48秒前
超帅发夹发布了新的文献求助10
48秒前
高分求助中
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 800
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 600
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 300
The Impact of Lease Accounting Standards on Lending and Investment Decisions 250
The Linearization Handbook for MILP Optimization: Modeling Tricks and Patterns for Practitioners (MILP Optimization Handbooks) 200
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5851979
求助须知:如何正确求助?哪些是违规求助? 6275055
关于积分的说明 15627539
捐赠科研通 4967924
什么是DOI,文献DOI怎么找? 2678842
邀请新用户注册赠送积分活动 1623057
关于科研通互助平台的介绍 1579488